390 related articles for article (PubMed ID: 26695166)
1. Misuse of Methylphenidate.
Clemow DB
Curr Top Behav Neurosci; 2017; 34():99-124. PubMed ID: 26695166
[TBL] [Abstract][Full Text] [Related]
2. The potential for misuse and abuse of medications in ADHD: a review.
Clemow DB; Walker DJ
Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
[TBL] [Abstract][Full Text] [Related]
3. Physician Training and Qualification to Educate Patients on Attention-Deficit/Hyperactivity Disorder Stimulant Diversion and Misuse.
Colaneri N; Keim SA; Adesman A
J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):554-561. PubMed ID: 30124331
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of ADHD symptom malingering, nonmedical use, and drug diversion among college-enrolled adults with a prescription for stimulant medications.
Ramachandran S; Dertien D; Bentley SI
J Addict Dis; 2020; 38(2):176-185. PubMed ID: 32242510
[TBL] [Abstract][Full Text] [Related]
5. Stimulant prescription cautions: addressing misuse, diversion and malingering.
Rabiner DL
Curr Psychiatry Rep; 2013 Jul; 15(7):375. PubMed ID: 23712725
[TBL] [Abstract][Full Text] [Related]
6. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
7. Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users.
Darredeau C; Barrett SP; Jardin B; Pihl RO
Hum Psychopharmacol; 2007 Dec; 22(8):529-36. PubMed ID: 17910020
[TBL] [Abstract][Full Text] [Related]
8. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
Kollins SH
J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
[TBL] [Abstract][Full Text] [Related]
9. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
Wilens TE; Adler LA; Adams J; Sgambati S; Rotrosen J; Sawtelle R; Utzinger L; Fusillo S
J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):21-31. PubMed ID: 18174822
[TBL] [Abstract][Full Text] [Related]
10. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
12. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots.
Poulin C
Addiction; 2007 May; 102(5):740-51. PubMed ID: 17506151
[TBL] [Abstract][Full Text] [Related]
13. Physician practices to prevent ADHD stimulant diversion and misuse.
Colaneri N; Keim S; Adesman A
J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
[TBL] [Abstract][Full Text] [Related]
14. The diversion of stimulant medications among a convenience sample of college students with current prescriptions.
Gallucci AR; Martin RJ; Usdan SL
Psychol Addict Behav; 2015 Mar; 29(1):154-61. PubMed ID: 25134041
[TBL] [Abstract][Full Text] [Related]
15. [Methylphenidate misuse].
Bruggisser M; Bodmer M; Liechti ME
Praxis (Bern 1994); 2012 Feb; 101(5):299-305. PubMed ID: 22377977
[TBL] [Abstract][Full Text] [Related]
16. Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008.
Frauger E; Pauly V; Natali F; Pradel V; Reggio P; Coudert H; Thirion X; Micallef J
CNS Drugs; 2011 May; 25(5):415-24. PubMed ID: 21476612
[TBL] [Abstract][Full Text] [Related]
17. Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system.
Cassidy TA; McNaughton EC; Varughese S; Russo L; Zulueta M; Butler SF
J Atten Disord; 2015 Apr; 19(4):275-83. PubMed ID: 23900405
[TBL] [Abstract][Full Text] [Related]
18. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
Kollins SH
Am J Addict; 2007; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
[TBL] [Abstract][Full Text] [Related]
19. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use.
Arria AM; Caldeira KM; O'Grady KE; Vincent KB; Johnson EP; Wish ED
Pharmacotherapy; 2008 Feb; 28(2):156-69. PubMed ID: 18225963
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
